EP1658032B1 - Therapeutic treatment appliance - Google Patents
Therapeutic treatment appliance Download PDFInfo
- Publication number
- EP1658032B1 EP1658032B1 EP04761018.3A EP04761018A EP1658032B1 EP 1658032 B1 EP1658032 B1 EP 1658032B1 EP 04761018 A EP04761018 A EP 04761018A EP 1658032 B1 EP1658032 B1 EP 1658032B1
- Authority
- EP
- European Patent Office
- Prior art keywords
- therapeutic treatment
- treatment device
- frequency band
- sine wave
- wave generator
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 238000011282 treatment Methods 0.000 title claims description 25
- 230000001225 therapeutic effect Effects 0.000 title claims description 23
- 230000005236 sound signal Effects 0.000 claims description 4
- 230000010355 oscillation Effects 0.000 claims 4
- 230000003213 activating effect Effects 0.000 claims 1
- 210000000988 bone and bone Anatomy 0.000 description 10
- 210000003205 muscle Anatomy 0.000 description 10
- 210000000056 organ Anatomy 0.000 description 9
- QZAYGJVTTNCVMB-UHFFFAOYSA-N serotonin Chemical compound C1=C(O)C=C2C(CCN)=CNC2=C1 QZAYGJVTTNCVMB-UHFFFAOYSA-N 0.000 description 8
- 229940088597 hormone Drugs 0.000 description 6
- 239000005556 hormone Substances 0.000 description 6
- 210000003041 ligament Anatomy 0.000 description 6
- 238000000034 method Methods 0.000 description 5
- 210000001835 viscera Anatomy 0.000 description 5
- MUMGGOZAMZWBJJ-DYKIIFRCSA-N Testostosterone Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 MUMGGOZAMZWBJJ-DYKIIFRCSA-N 0.000 description 4
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 4
- 210000001519 tissue Anatomy 0.000 description 4
- UCTWMZQNUQWSLP-UHFFFAOYSA-N Adrenaline Natural products CNCC(O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-UHFFFAOYSA-N 0.000 description 3
- 230000008878 coupling Effects 0.000 description 3
- 238000010168 coupling process Methods 0.000 description 3
- 238000005859 coupling reaction Methods 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 125000000524 functional group Chemical class 0.000 description 3
- 210000000664 rectum Anatomy 0.000 description 3
- SFLSHLFXELFNJZ-QMMMGPOBSA-N (-)-norepinephrine Chemical compound NC[C@H](O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-QMMMGPOBSA-N 0.000 description 2
- JLTCWSBVQSZVLT-CDIPANDDSA-N (2s)-n-[(2s)-6-amino-1-[(2-amino-2-oxoethyl)amino]-1-oxohexan-2-yl]-1-[(4r,7s,10s,13s,16s,19r)-19-amino-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13-benzyl-16-[(4-hydroxyphenyl)methyl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosan Chemical compound NCCCC[C@@H](C(=O)NCC(N)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H]1NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC=2C=CC=CC=2)NC(=O)[C@H](CC=2C=CC(O)=CC=2)NC(=O)[C@@H](N)CSSC1.C([C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CSSC[C@@H](C(N[C@@H](CC=2C=CC(O)=CC=2)C(=O)N1)=O)N)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)C1=CC=CC=C1 JLTCWSBVQSZVLT-CDIPANDDSA-N 0.000 description 2
- UCTWMZQNUQWSLP-VIFPVBQESA-N (R)-adrenaline Chemical compound CNC[C@H](O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-VIFPVBQESA-N 0.000 description 2
- 102000004877 Insulin Human genes 0.000 description 2
- 108090001061 Insulin Proteins 0.000 description 2
- YJPIGAIKUZMOQA-UHFFFAOYSA-N Melatonin Natural products COC1=CC=C2N(C(C)=O)C=C(CCN)C2=C1 YJPIGAIKUZMOQA-UHFFFAOYSA-N 0.000 description 2
- 108010070873 Posterior Pituitary Hormones Proteins 0.000 description 2
- 102000005320 Posterior Pituitary Hormones Human genes 0.000 description 2
- GXBMIBRIOWHPDT-UHFFFAOYSA-N Vasopressin Natural products N1C(=O)C(CC=2C=C(O)C=CC=2)NC(=O)C(N)CSSCC(C(=O)N2C(CCC2)C(=O)NC(CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(CCC(N)=O)NC(=O)C1CC1=CC=CC=C1 GXBMIBRIOWHPDT-UHFFFAOYSA-N 0.000 description 2
- 108010004977 Vasopressins Proteins 0.000 description 2
- 102000002852 Vasopressins Human genes 0.000 description 2
- 210000000436 anus Anatomy 0.000 description 2
- KBZOIRJILGZLEJ-LGYYRGKSSA-N argipressin Chemical compound C([C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CSSC[C@@H](C(N[C@@H](CC=2C=CC(O)=CC=2)C(=O)N1)=O)N)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)C1=CC=CC=C1 KBZOIRJILGZLEJ-LGYYRGKSSA-N 0.000 description 2
- 210000002745 epiphysis Anatomy 0.000 description 2
- 229940125396 insulin Drugs 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 210000002751 lymph Anatomy 0.000 description 2
- 229960003987 melatonin Drugs 0.000 description 2
- DRLFMBDRBRZALE-UHFFFAOYSA-N melatonin Chemical compound COC1=CC=C2NC=C(CCNC(C)=O)C2=C1 DRLFMBDRBRZALE-UHFFFAOYSA-N 0.000 description 2
- 210000005036 nerve Anatomy 0.000 description 2
- 230000003534 oscillatory effect Effects 0.000 description 2
- 210000003635 pituitary gland Anatomy 0.000 description 2
- 210000002307 prostate Anatomy 0.000 description 2
- 230000029058 respiratory gaseous exchange Effects 0.000 description 2
- 229940076279 serotonin Drugs 0.000 description 2
- 230000000638 stimulation Effects 0.000 description 2
- 210000002435 tendon Anatomy 0.000 description 2
- 210000000115 thoracic cavity Anatomy 0.000 description 2
- 229960003726 vasopressin Drugs 0.000 description 2
- 208000006820 Arthralgia Diseases 0.000 description 1
- 208000008035 Back Pain Diseases 0.000 description 1
- 241000511343 Chondrostoma nasus Species 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- XUIIKFGFIJCVMT-GFCCVEGCSA-N D-thyroxine Chemical compound IC1=CC(C[C@@H](N)C(O)=O)=CC(I)=C1OC1=CC(I)=C(O)C(I)=C1 XUIIKFGFIJCVMT-GFCCVEGCSA-N 0.000 description 1
- 206010011878 Deafness Diseases 0.000 description 1
- 108010000437 Deamino Arginine Vasopressin Proteins 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 206010062767 Hypophysitis Diseases 0.000 description 1
- 208000000913 Kidney Calculi Diseases 0.000 description 1
- 208000019695 Migraine disease Diseases 0.000 description 1
- 208000007101 Muscle Cramp Diseases 0.000 description 1
- 206010029148 Nephrolithiasis Diseases 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 206010033433 Pain in jaw Diseases 0.000 description 1
- 206010038490 Renal pain Diseases 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 208000009205 Tinnitus Diseases 0.000 description 1
- 210000000683 abdominal cavity Anatomy 0.000 description 1
- 210000004100 adrenal gland Anatomy 0.000 description 1
- 229940102884 adrenalin Drugs 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 210000003403 autonomic nervous system Anatomy 0.000 description 1
- 230000008827 biological function Effects 0.000 description 1
- 208000002352 blister Diseases 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 210000000621 bronchi Anatomy 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 210000001638 cerebellum Anatomy 0.000 description 1
- 210000004720 cerebrum Anatomy 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 210000000038 chest Anatomy 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 201000003146 cystitis Diseases 0.000 description 1
- 229960004281 desmopressin Drugs 0.000 description 1
- NFLWUMRGJYTJIN-NXBWRCJVSA-N desmopressin Chemical compound C([C@H]1C(=O)N[C@H](C(N[C@@H](CC(N)=O)C(=O)N[C@@H](CSSCCC(=O)N[C@@H](CC=2C=CC(O)=CC=2)C(=O)N1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(N)=O)=O)CCC(=O)N)C1=CC=CC=C1 NFLWUMRGJYTJIN-NXBWRCJVSA-N 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 210000002249 digestive system Anatomy 0.000 description 1
- 210000005069 ears Anatomy 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 210000003238 esophagus Anatomy 0.000 description 1
- 229940011871 estrogen Drugs 0.000 description 1
- 239000000262 estrogen Substances 0.000 description 1
- 210000001061 forehead Anatomy 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 210000002149 gonad Anatomy 0.000 description 1
- 230000010370 hearing loss Effects 0.000 description 1
- 231100000888 hearing loss Toxicity 0.000 description 1
- 208000016354 hearing loss disease Diseases 0.000 description 1
- 210000002216 heart Anatomy 0.000 description 1
- 210000001624 hip Anatomy 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 208000024765 knee pain Diseases 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 210000002414 leg Anatomy 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 206010027599 migraine Diseases 0.000 description 1
- 201000008383 nephritis Diseases 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 229960002748 norepinephrine Drugs 0.000 description 1
- SFLSHLFXELFNJZ-UHFFFAOYSA-N norepinephrine Natural products NCC(O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-UHFFFAOYSA-N 0.000 description 1
- 210000001331 nose Anatomy 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 210000001672 ovary Anatomy 0.000 description 1
- 210000000496 pancreas Anatomy 0.000 description 1
- 210000002990 parathyroid gland Anatomy 0.000 description 1
- 210000004197 pelvis Anatomy 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 210000004560 pineal gland Anatomy 0.000 description 1
- 230000001817 pituitary effect Effects 0.000 description 1
- 230000036544 posture Effects 0.000 description 1
- 230000001850 reproductive effect Effects 0.000 description 1
- 210000000582 semen Anatomy 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 210000003625 skull Anatomy 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 210000001550 testis Anatomy 0.000 description 1
- 229960003604 testosterone Drugs 0.000 description 1
- 210000001541 thymus gland Anatomy 0.000 description 1
- 239000000724 thymus hormone Substances 0.000 description 1
- 210000001685 thyroid gland Anatomy 0.000 description 1
- 229940034208 thyroxine Drugs 0.000 description 1
- XUIIKFGFIJCVMT-UHFFFAOYSA-N thyroxine-binding globulin Natural products IC1=CC(CC([NH3+])C([O-])=O)=CC(I)=C1OC1=CC(I)=C(O)C(I)=C1 XUIIKFGFIJCVMT-UHFFFAOYSA-N 0.000 description 1
- 231100000886 tinnitus Toxicity 0.000 description 1
- 230000001755 vocal effect Effects 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61H—PHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
- A61H23/00—Percussion or vibration massage, e.g. using supersonic vibration; Suction-vibration massage; Massage with moving diaphragms
- A61H23/02—Percussion or vibration massage, e.g. using supersonic vibration; Suction-vibration massage; Massage with moving diaphragms with electric or magnetic drive
- A61H23/0218—Percussion or vibration massage, e.g. using supersonic vibration; Suction-vibration massage; Massage with moving diaphragms with electric or magnetic drive with alternating magnetic fields producing a translating or oscillating movement
- A61H23/0236—Percussion or vibration massage, e.g. using supersonic vibration; Suction-vibration massage; Massage with moving diaphragms with electric or magnetic drive with alternating magnetic fields producing a translating or oscillating movement using sonic waves, e.g. using loudspeakers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61H—PHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
- A61H2201/00—Characteristics of apparatus not provided for in the preceding codes
- A61H2201/01—Constructive details
- A61H2201/0119—Support for the device
- A61H2201/0138—Support for the device incorporated in furniture
- A61H2201/0142—Beds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61H—PHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
- A61H2205/00—Devices for specific parts of the body
- A61H2205/04—Devices for specific parts of the body neck
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61H—PHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
- A61H2205/00—Devices for specific parts of the body
- A61H2205/08—Trunk
- A61H2205/081—Back
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61H—PHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
- A61H2205/00—Devices for specific parts of the body
- A61H2205/10—Leg
Definitions
- the invention relates to a therapeutic treatment device according to the preamble of claim 1.
- Therapeutic treatments using manual treatment techniques are well known.
- the hands of the therapist exert tensile and compressive forces to relax the ligaments and muscles of the patient, which depending on the indication and treatment technique shows therapeutic effect, such as a mobilization of joints, better removal of body fluids such as lymph, improved circulation of tissues and organs and much more.
- treatment techniques of this type have a local character, i. the therapeutic intervention by touch is always confined to a narrowly defined region of the body, although the effect of this therapeutic intervention may well radiate to the entire body of the patient, as is the case with osteopathic treatment techniques.
- Kidney pain for example, is not always due to nephritis or kidney stones. It can also be the hip muscle, on which the kidney rises and falls around 600 times a day while breathing. If this muscle is cramped, for example due to crooked posture, respiration and kidney function are impaired.
- osteopathic treatment techniques with targeted gentle pressure massage with the fingertips muscle spasms are resolved, ligaments stretched and Bonding and adhesions loosened. Good results are achieved, for example, in the case of back, knee and jaw pain, diarrhea and constipation, migraine and irregular symptoms, chronic sinus and bladder infections, hearing loss, tinnitus or even asthma.
- the first functional circuit a frequency band of 31 Hz to 33 Hz
- the second functional circuit a frequency band from 35.5 Hz to 37.5 Hz
- the third functional circuit a frequency band from 40 Hz to 42.5 Hz
- the fourth circuit a frequency band from 44.5 Hz to 46.5 Hz
- the fifth functional circuit a frequency band from 49 Hz to 51 Hz
- the sixth functional circuit a frequency band from 54 Hz to 56 Hz
- the seventh function circle a Frenquenzband be assigned from 58.5 Hz to 60.5 Hz.
- the aim of the invention is thus a therapeutic treatment device that uses the facts of different functional circuits and allows stimulation of individual functional circuits on their resonance frequencies. This object is achieved by the implementation of the measures according to claim 1.
- Claim 1 provides for a therapeutic treatment device with a support surface for the patient, wherein below the support surface at least one sound body is attached, the sound waves having a frequency below 100 Hz generated, which are within predetermined, discrete frequency bands, and a control unit with multiple controls for Control of the at least one sound body is provided.
- a first frequency band extends from 31 Hz to 33 Hz, a second frequency band from 35.5 Hz to 37.5 Hz, a third frequency band from 40 Hz to 42.5 Hz, a fourth frequency band from 44.5 Hz up to 46.5 Hz, a fifth frequency band from 49 Hz to 51 Hz, a sixth frequency band from 54 Hz to 56 Hz, and a seventh frequency band from 58.5 Hz to 60.5 Hz, one control element each being assigned to one of these discrete frequency bands and permitting its selection ,
- the resonance frequencies of the functional circuits are the resonance frequencies of the functional circuits. If it is assumed that there are seven functional circuits, then seven frequency bands will be provided within each of which the resonance frequency of a functional circuit is located. Although physical systems have very sharply defined resonance frequencies, this is not the case with the biological function circuits in question, so here we are talking about frequency bands. In principle, it is assumed that due to this blurring of the resonance frequency, different frequencies within a frequency band are equally suitable for stimulating the respective functional circuit. Frequencies outside of this frequency band can no longer stimulate the corresponding functional circuit since they are too out of resonance with the relevant functional circuit in order to be therapeutically interesting. Depending on the therapeutic indication, one or more frequencies, preferably one after the other, are thus generated for a certain period of time and thus different functional circuits are treated.
- a specialized device for the treatment of a particular functional circuit provides the reproduction of only one frequency.
- the operating unit achieves easy operability of the at least one sound body, since the operator only has to actuate a control element, such as a push button, a switch or a selectable computer mouse selection field of a corresponding software program, so as to select a particular frequency band.
- Claim 2 provides an advantageous embodiment of the treatment device to which exactly two sound bodies are provided as a result.
- Claim 3 a be arranged below the support surface so that it comes to rest on the support surface below the pelvic region of the patient and the second below the chest area when a patient is supported.
- the entire body of the patient can be optimally sonicated.
- the operating unit is equipped with a control element for amplitude modulation of the sound waves of the at least one sound body.
- the claims 5 to 8 provide that a sine wave generator and a pulse shaper are provided, wherein the pulse shaper converts the sine waves generated by the sine wave generator into a sawtooth, square wave, triangular wave or a pulsed wave.
- the pulse shaper converts the sine waves generated by the sine wave generator into a sawtooth, square wave, triangular wave or a pulsed wave.
- the at least one sound body of the treatment device according to the invention is driven approximately via a commercially available CD player, wherein the CD used contains audio frequencies within the above-specified frequency bands as audio information. Therefore claim 9 claims treatment devices with storage media for audio signals, such as CDs, wherein the audio signals substantially
Landscapes
- Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Physical Education & Sports Medicine (AREA)
- Rehabilitation Therapy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Percussion Or Vibration Massage (AREA)
Description
Die Erfindung bezieht sich auf ein therapeutisches Behandlungsgerät gemäß dem Oberbegriff von Anspruch 1.The invention relates to a therapeutic treatment device according to the preamble of
Therapeutische Behandlungen mithilfe manueller Behandlungstechniken sind wohlbekannt. Dabei üben die Hände des Therapeuten Zug- und Druckkräften zur Lockerung der Bänder und Muskeln des Patienten aus, was je nach Indikation und Behandlungstechnik therapeutische Wirkung zeigt, etwa eine Mobilisierung von Gelenken, bessere Abfuhr von Körperflüssigkeiten wie etwa Lymphflüssigkeit, verbesserte Durchblutung von Geweben und Organen und vieles mehr. Durch den Einsatz der Hände des Therapeuten haben Behandlungstechniken dieser Art lokalen Charakter, d.h. die therapeutische Intervention durch Berührung ist stets auf eine eng begrenzte Körperregion beschränkt, wenngleich die Wirkung dieser therapeutischen Intervention durchaus auf den gesamten Körper des Patienten ausstrahlen kann, wie dies etwa bei osteopathischen Behandlungstechniken der Fall ist.Therapeutic treatments using manual treatment techniques are well known. The hands of the therapist exert tensile and compressive forces to relax the ligaments and muscles of the patient, which depending on the indication and treatment technique shows therapeutic effect, such as a mobilization of joints, better removal of body fluids such as lymph, improved circulation of tissues and organs and much more. Through the use of the therapist's hands, treatment techniques of this type have a local character, i. the therapeutic intervention by touch is always confined to a narrowly defined region of the body, although the effect of this therapeutic intervention may well radiate to the entire body of the patient, as is the case with osteopathic treatment techniques.
Behandlungsmethoden dieser Art betrachten die einzelnen Organe nicht isoliert, sondern vermuten, dass Schmerzen in einem Körperteil ihre Ursache ganz woanders haben können. Innere Organe und Knochen sind über Bänder, Muskeln und Nerven miteinander verbunden. Ist ein Körperteil krank oder verletzt, können in einer Art Kettenreaktion andere Organe gestört werden. So sind zum Beispiel an Nierenschmerzen nicht immer eine Nierenentzündung oder Nierensteine schuld. Es kann auch der Hüftmuskel sein, auf dem die Niere beim Atmen täglich rund 600mal auf- und abgleitet. Ist dieser Muskel verkrampft, z.B. durch schiefe Körperhaltung, werden Atmung und Nierenfunktion mit beeinträchtigt. Bei osteopathischen Behandlungstechniken werden mit gezielten, sanften Druckmassagen mit den Fingerspitzen Muskel-Verkrampfungen gelöst, Bänder gedehnt und Verklebungen und Verwachsungen gelockert. Gute Resultate werden hierbei etwa bei Rücken-, Knie- und Kieferschmerzen, Durchfall und Verstopfung, Migräne und Regelbeschwerden, bei chronischen Nebenhöhlen- und Blasenentzündungen, bei Hörsturz, Tinnitus oder auch Asthma erzielt.Treatments of this kind do not look at the individual organs in isolation, but suggest that pain in one part of the body may be due elsewhere. Internal organs and bones are connected by ligaments, muscles and nerves. If a part of the body is ill or injured, other organs can be disturbed in a kind of chain reaction. Kidney pain, for example, is not always due to nephritis or kidney stones. It can also be the hip muscle, on which the kidney rises and falls around 600 times a day while breathing. If this muscle is cramped, for example due to crooked posture, respiration and kidney function are impaired. In osteopathic treatment techniques with targeted, gentle pressure massage with the fingertips muscle spasms are resolved, ligaments stretched and Bonding and adhesions loosened. Good results are achieved, for example, in the case of back, knee and jaw pain, diarrhea and constipation, migraine and irregular symptoms, chronic sinus and bladder infections, hearing loss, tinnitus or even asthma.
Die relative Lage der über Bänder, Muskeln und Nerven miteinander verbundenen inneren Organe und Knochen ist selbstverständlich veränderlich, innere Organe und Knochen können gegeneinander geringfügig verschoben werden. Aus mechanischer Sicht bilden Bänder, Filamente, Sehnen und Muskeln elastische Kopplungen zwischen inneren Organen und Knochen, wobei die relative Lage von inneren Organen und Knochen wiederum auf die sie verbindenden Bänder, Filamente, Sehnen und Muskeln rückwirkt. Aus mechanischer Sicht sind dadurch Kopplungskreise verwirklicht, die schwingfähige Systeme- darstellen. Durch die Art und Stärke der (Rück-) Kopplung werden bestimmte Organe und Knochen mit dem einen oder anderen Organ, Muskel, Gewebe oder Knochen in stärkerer gegenseitiger Verbindung stehen als mit anderen. Es ist daher zu erwarten, dass bestimmte Organe, Muskel, Gewebe oder Knochen ein gemeinsames, schwingfähiges System bilden und als solches identifiziert werden können, was gemäß Schwingungslehre der Physik auch als Schwingkreis bezeichnet werden kann. Des weiteren werden andere Organe, Muskel, Gewebe oder Knochen andere Schwingkreise bilden. Diese unterschiedlichen Schwingkreise sollten über ihre Resonanzfrequenzen auffindbar und identifizierbar sein. Im folgenden wird jedoch für diese Schwingkreise der Begriff "Funktionskreis" verwendet, da die praktische Erfahrung des Anmelders zeigt, dass diesen Schwingkreisen etwa -auch bestimmte Drüsen sowie Hormone zugeordnet sind. Die Vorstellung eines bloß mechanischen, schwingfähigen Systems würde daher zu kurz greifen. Stattdessen sind diese Schwingkreise mit bestimmten physiologischen Funktionen verknüpft, sodass der Begriff Funktionskreis passender erscheint.Of course, the relative position of the internal organs and bones interconnected by ligaments, muscles and nerves is variable, internal organs and bones can be shifted slightly against each other. From a mechanical point of view, ligaments, filaments, tendons and muscles form elastic couplings between internal organs and bones, with the relative position of internal organs and bones reacting on the ligaments, filaments, tendons and muscles connecting them. From a mechanical point of view, coupling circuits are realized that represent oscillatory systems. Due to the nature and strength of the (re) coupling, certain organs and bones will be more closely connected to one or the other organ, muscle, tissue or bone than to others. It is therefore to be expected that certain organs, muscles, tissues or bones can form a common, vibratory system and can be identified as such, which according to vibrational theory of physics can also be referred to as a resonant circuit. Furthermore, other organs, muscle, tissue or bone will form other resonant circuits. These different resonant circuits should be discoverable and identifiable via their resonance frequencies. In the following, however, the term "functional circuit" is used for these resonant circuits, since the practical experience of the applicant shows that these oscillators are also associated with certain glands and hormones. The idea of a merely mechanical, oscillatory system would therefore be too short. Instead, these resonant circuits are linked to certain physiological functions, so that the term function circle appears more appropriate.
Tatsächlich legen theoretische und praktische Untersuchungen des Anmelders sieben Funktionskreise nahe:
- Der erste Funktionskreis umfasst die festen Komponenten Wirbelsäule, Knochen, Zähne und Nägel sowie beide Beine, Anus, Rektum, Dickdarm, Mastdarm, Enddarm sowie die Prostata. Diesem Funktionskreis können die Nebennierendrüsen sowie die Hormone Adrenalin und Noradrenalin zugeordnet werden. Des weiteren scheint hinsichtlich der physiologischen Verknüpfung das Blut sowie der allgemeine Zellaufbau besonders mit diesem Funktionskreis verknüpft zu sein.
- Der zweite Funktionskreis umfasst den Beckenraum, die Fortpflanzungsorgane, die Nieren und die Blase. Diesem Funktionskreis können die Keimdrüsen, die Eierstöcke, die Hoden und auch die Prostata sowie die Östrogene und Testosteron zugeordnet werden. Des weiteren scheint hinsichtlich der physiologischen Verknüpfung die Lymphe, die Verdauungssäfte sowie das Sperma besonders mit diesem Funktionskreis verknüpft zu sein.
- Der dritte Funktionskreis umfasst den unteren Rücken, die Bauchhöhle, das Verdauungssystem, den Magen, die Leber, die Milz und die Gallenblase. Diesem Funktionskreis können die Bauchspeicheldrüse sowie das Insulin zugeordnet werden. Des weiteren scheint hinsichtlich der physiologischen Verknüpfung das vegetative Nervensystem besonders mit diesem Funktionskreis verknüpft zu sein.
- Der vierte Funktionskreis umfasst den oberen Rücken, das Herz, den Brustkorb und die Brusthöhle, den unteren Lungenbereich sowie die Haut und die Hände. Diesem Funktionskreis können die Thymusdrüse und das Thymushormon zugeordnet werden. Des weiteren scheint hinsichtlich der physiologischen Verknüpfung das Blutkreislaufsystem besonders mit diesem Funktionskreis verknüpft zu sein.
- Der fünfte Funktionskreis umfasst die Lunge, die Bronchien, die Speiseröhre, den Sprechapparat, die Kehle, den Nacken, den Kiefer und die Kinnbacken. Diesem Funktionskreis können die Schilddrüse und die Nebenschilddrüse sowie das Hormon Thyroxin zugeordnet werden.
- Der sechste Funktionskreis umfasst das Kleinhirn, die Ohren, die Nase, die Nebenhöhlen, die Augen, die Stirn und das Gesicht. Diesem Funktionskreis können die Hirnanhangdrüse (Hypophyse) sowie das Hormon Vasopressin (Adiuretin) sowie Pituitrin zugeordnet werden. Des weiteren scheint hinsichtlich der physiologischen Verknüpfung das Nervensystem besonders mit diesem Funktionskreis verknüpft zu sein.
- Der siebente Funktionskreis umfasst das Großhirn sowie die Schädeldecke. Diesem Funktionskreis können die Zirbeldrüse (Epiphyse) sowie das Hormon Serotonin (Enteramin) und Melatonin zugeordnet werden.
- The first functional circuit includes the fixed components spine, bones, teeth and nails as well as both legs, anus, rectum, large intestine, rectum, rectum and the prostate. This functional circuit can be assigned to the adrenal glands as well as the hormones adrenaline and norepinephrine. Furthermore, with regard to the physiological linkage, the blood as well as the general cell structure seems to be particularly linked to this functional circuit.
- The second functional circuit includes the pelvic area, the reproductive organs, the kidneys and the bladder. This functional circuit can be assigned to the gonads, the ovaries, the testes and also the prostate as well as the estrogens and testosterone. Furthermore, with regard to the physiological linkage, the lymph, the digestive juices and the semen appear to be particularly associated with this functional group.
- The third functional circuit includes the lower back, the abdominal cavity, the digestive system, the stomach, the liver, the spleen, and the gallbladder. This circuit can be assigned to the pancreas and insulin. Furthermore, with regard to the physiological linkage, the autonomic nervous system seems to be particularly associated with this functional group.
- The fourth functional circuit includes the upper back, heart, chest and thoracic cavity, lower lung area, skin and hands. This functional circuit can be assigned to the thymus gland and the thymic hormone. Furthermore, in terms of physiological linkage, the circulatory system appears to be particularly associated with this functional circuit.
- The fifth functional circuit includes the lungs, bronchi, esophagus, the vocal tract, throat, neck, jaw, and jawbones. This functional circuit can be assigned to the thyroid gland and the parathyroid gland as well as the hormone thyroxine.
- The sixth circle of functions includes the cerebellum, ears, nose, sinuses, eyes, forehead, and face. This functional circuit can be assigned to the pituitary gland (pituitary) as well as the hormone vasopressin (adiuretine) and pituitrin. Furthermore, with regard to the physiological linkage, the nervous system seems to be particularly linked to this functional group.
- The seventh functional circuit includes the cerebrum and the skull. This circuit can be assigned to the pineal gland (epiphysis) as well as the hormones serotonin (enteramine) and melatonin.
Für eine therapeutische Interaktion mit diesen Funktionskreisen ist aber die bloße manuelle Manipulation, die zumeist nur lokal ansetzt, unzureichend. Es hat sich nun herausgestellt, dass diesen Funktionskreisen tatsächlich Resonanzfrequenzen zugeordnet werden können, über die eine Stimulierung des gesamten Funktionskreises erreicht werden kann. Da diese Funktionskreise aus physikalischer Sicht mechanische Systeme mit Größenordnungen von Zentimetern bis Metern sind, ist zu erwarten, dass die Resonanzfrequenzen in der Größenordnung von 20 Hz bis 100 Hz liegen und dass sich jede einzelne Resonanzfrequenz in engen diskreten Frequenzbändern bewegt, wie dies für Schwingkreise der Fall ist. Genau dieser Sachverhalt wurde in der therapeutischen Praxis beobachtet. So konnte dem ersten Funktionskreis ein Frequenzband von 31 Hz bis 33 Hz, dem zweiten Funktionskreis ein Frequenzband von 35.5 Hz bis 37.5 Hz, dem dritten Funktionskreis ein Frequenzband von 40 Hz bis 42.5 Hz, dem vierten Funktionskreis ein Frequenzband von 44.5 Hz bis 46.5 Hz, dem fünften Funktionskreis ein Frequenzband von 49 Hz bis 51 Hz, dem sechsten Funktionskreis ein Frequenzband von 54 Hz bis 56 Hz und dem siebenten Funktionskreis ein Frenquenzband von 58.5 Hz bis 60.5 Hz zugeordnet werden.For a therapeutic interaction with these functional circuits, however, the mere manual manipulation, which usually only addresses locally, is inadequate. It has now been found that resonant frequencies can actually be assigned to these functional circuits, via which stimulation of the entire functional circuit can be achieved. Since these functional circuits are mechanical systems with dimensions of centimeters to meters from a physical point of view, it is to be expected that the resonance frequencies are in the order of 20 Hz to 100 Hz and that each individual resonance frequency moves in narrow discrete frequency bands, as is the case for oscillating circuits Case is. Exactly this fact was observed in therapeutic practice. Thus, the first functional circuit, a frequency band of 31 Hz to 33 Hz, the second functional circuit, a frequency band from 35.5 Hz to 37.5 Hz, the third functional circuit a frequency band from 40 Hz to 42.5 Hz, the fourth circuit a frequency band from 44.5 Hz to 46.5 Hz, the fifth functional circuit a frequency band from 49 Hz to 51 Hz, the sixth functional circuit a frequency band from 54 Hz to 56 Hz and the seventh function circle a Frenquenzband be assigned from 58.5 Hz to 60.5 Hz.
Aus der
Ziel der Erfindung ist somit ein therapeutisches Behandlungsgerät, das den Sachverhalt unterschiedlicher Funktionskreise nützt und eine Stimulation einzelner Funktionskreise über deren Resonanzfrequenzen gestattet. Dieses Ziel wird durch die Verwirklichung der Maßnahmen gemäß Anspruch 1 erreicht.The aim of the invention is thus a therapeutic treatment device that uses the facts of different functional circuits and allows stimulation of individual functional circuits on their resonance frequencies. This object is achieved by the implementation of the measures according to
Anspruch 1 sieht hierbei ein therapeutisches Behandlungsgerät mit einer Auflagefläche für den Patienten vor, wobei unterhalb der Auflagefläche mindestens ein Schallkörper befestigt ist, der Schallwellen mit einer Frequenz unter 100 Hz erzeugt, die innerhalb vorgegebener, diskreter Frequenzbänder liegen, sowie eine Bedieneinheit mit mehreren Bedienelementen zur Ansteuerung des mindestens einen Schallkörpers vorgesehen ist. Erfindungsgemäß ist nun vorgesehen, dass sich ein erstes Frequenzband von 31 Hz bis 33 Hz erstreckt, ein zweites Frequenzband von 35.5 Hz bis 37.5 Hz, ein drittes Frequenzband von 40 Hz bis 42.5 Hz, ein viertes Frequenzband von 44.5 Hz bis 46.5 Hz, ein fünftes Frequenzband von 49 Hz bis 51 Hz, ein sechstes Frequenzband von 54 Hz bis 56 Hz, und ein siebentes Frequenzband von 58.5 Hz bis 60.5 Hz, wobei je ein Bedienelement je einem dieser diskreten Frequenzbänder zugeordnet ist und dessen Auswahl ermöglicht.
In den einzelnen Frequenzbändern liegen die Resonanzfrequenzen der Funktionskreise. Sofern von sieben Funktionskreisen ausgegangen wird, werden somit sieben Frequenzbänder vorgesehen sein, innerhalb derer jeweils die Resonanzfrequenz eines Funktionskreises liegt. Wenngleich physikalische Systeme sehr scharf definierte Resonanzfrequenzen aufweisen, ist dies bei den gegenständlichen biologischen Funktionskreisen nicht der Fall, sodass hier von Frequenzbändern gesprochen wird. Prinzipiell wird davon ausgegangen, dass aufgrund dieser Unschärfe der Resonanzfrequenz unterschiedliche Frequenzen innerhalb eines Frequenzbandes gleichermaßen geeignet sind den jeweiligen Funktionskreis anzuregen. Frequenzen außerhalb dieses Frequenzbandes können den entsprechenden Funktionskreis nicht mehr anregen, da sie zu stark außer Resonanz mit dem betreffenden Funktionskreis sind, um therapeutisch interessant sein zu können. Je nach therapeutischer Indikation werden somit eine oder auch mehrere Frequenzen, vorzugsweise nacheinander, für eine bestimmte Zeitdauer erzeugt und damit unterschiedliche Funktionskreise behandelt. Selbstverständlich ist es auch denkbar, dass ein spezialisiertes Gerät zur Behandlung eines bestimmten Funktionskreises die Wiedergabe von lediglich einer Frequenz vorsieht. Durch die Bedieneinheit wird eine leichte Bedienbarkeit des mindestens einen Schallkörpers erreicht, da die Bedienperson lediglich ein Bedienelement, etwa ein Druckknopf, ein Schalter oder ein per Computer-Maus anwählbares Auswahlfeld eines entsprechenden Software-Programmes betätigen muss, um so ein bestimmtes Frequenzband anzuwählen.In the individual frequency bands are the resonance frequencies of the functional circuits. If it is assumed that there are seven functional circuits, then seven frequency bands will be provided within each of which the resonance frequency of a functional circuit is located. Although physical systems have very sharply defined resonance frequencies, this is not the case with the biological function circuits in question, so here we are talking about frequency bands. In principle, it is assumed that due to this blurring of the resonance frequency, different frequencies within a frequency band are equally suitable for stimulating the respective functional circuit. Frequencies outside of this frequency band can no longer stimulate the corresponding functional circuit since they are too out of resonance with the relevant functional circuit in order to be therapeutically interesting. Depending on the therapeutic indication, one or more frequencies, preferably one after the other, are thus generated for a certain period of time and thus different functional circuits are treated. Of course, it is also conceivable that a specialized device for the treatment of a particular functional circuit provides the reproduction of only one frequency. The operating unit achieves easy operability of the at least one sound body, since the operator only has to actuate a control element, such as a push button, a switch or a selectable computer mouse selection field of a corresponding software program, so as to select a particular frequency band.
Anspruch 2 sieht eine vorteilhafte Ausführung des Behandlungsgerätes vor, dem zu Folge genau zwei Schallkörper vorgesehen sind. Zweckmäßigerweise wird gemäß Anspruch 3 einer davon unterhalb der Auflagefläche so angeordnet werden, dass er bei Lagerung eines Patienten auf der Auflagefläche unterhalb des Beckenbereiches des Patienten und der zweite unterhalb des Brustbereiches zu liegen kommt. Damit kann der gesamte Körper des Patienten optimal beschallt werden.
Gemäß Anspruch 4 ist vorgesehen, dass die Bedieneinheit mit einem Bedienelement zur Amplitudenmodulation der Schallwellen des mindestens einen Schallkörpers ausgestattet ist. Dadurch kann auf unterschiedliche Empfindlichkeiten von Patienten Rücksicht genommen werden, oder auch die therapeutische Intervention unterschiedlich stark gestaltet werden.According to
Die Ansprüche 5 bis 8 sehen vor, dass ein Sinusgenerator sowie ein Impulsformer vorgesehen sind, wobei der Impulsformer die vom Sinusgenerator erzeugten Sinusschwingungen in eine Sägezahnschwingung, Rechtecksschwingung, Dreiecksschwingung oder eine gepulste Schwingung umwandelt. Diese unterschiedlichen Impulsformen weisen je nach deren Obertongehalt, Resonanzeigenschaften mit den jeweiligen Funktionskreisen oder impulscharakteristischem Energieeintrag unterschiedliche therapeutische Eigenschaften auf und ermöglichen somit Optimierungsmöglichkeiten in der therapeutischen Praxis.The
Des weiteren ist denkbar, dass der mindestens eine Schallkörper des erfindungsgemäßen Behandlungsgerätes etwa über einen handelsüblichen CD-Spieler angesteuert wird, wobei die verwendete CD als Audioinformation Tonfrequenzen innerhalb der oben spezifizierten Frequenzbänder enthält. Daher beansprucht Anspruch 9 Behandlungsgeräte mit Speichermedien für Audiosignale, etwa CDs, wobei die Audiosignale im wesentlichenFurthermore, it is conceivable that the at least one sound body of the treatment device according to the invention is driven approximately via a commercially available CD player, wherein the CD used contains audio frequencies within the above-specified frequency bands as audio information. Therefore claim 9 claims treatment devices with storage media for audio signals, such as CDs, wherein the audio signals substantially
Claims (9)
- A therapeutic treatment device having a contact surface for the patient, at least one acoustic body (1) being attached below the contact surface, which generates sound waves having a frequency below 100 Hz, which lie within predefined, discrete frequency bands, and an operating unit (4) having multiple operating elements (9) for activating the at least one acoustic body (1) being provided, characterized in that a first frequency band extends from 31 Hz to 33 Hz, a second frequency band extends from 35.5 Hz to 37.5 Hz, a third frequency band extends from 40 Hz to 42.5 Hz, a fourth frequency band extends from 44.5 Hz to 46.5 Hz, a fifth frequency band extends from 49 Hz to 51 Hz, a sixth frequency band extends from 54 Hz to 56 Hz, and a seventh frequency band extends from 58.5 Hz to 60.5 Hz, an operating element (9) being assigned to each of these discrete frequency bands and allowing its selection.
- The therapeutic treatment device according to Claim 1, characterized in that precisely two acoustic bodies (1) are provided.
- The therapeutic treatment device according to Claim 2, characterized in that the acoustic bodies (1) are positioned below the contact surface in such a way that when a patient reclines on the contact surface, one acoustic body (1) comes to rest below the pelvic area of the patient and the second acoustic body (1) comes to rest below the chest area of the patient.
- The therapeutic treatment device according to one of Claims 1 through 3, characterized in that the operating unit (4) is equipped with an operating element (10) for amplitude modulation of the sound waves of the at least one acoustic body (1).
- The therapeutic treatment device according to one of Claims 1 through 4, characterized in that a sine wave generator (11) and a pulse shaper (13) are provided, the pulse shaper (13) converting the sinusoidal oscillations generated by the sine wave generator (11) into a sawtooth vibration.
- The therapeutic treatment device according to one of Claims 1 through 5, characterized in that a sine wave generator (11) and a pulse shaper (13) are provided, the pulse shaper (13) converting the sinusoidal oscillations generated by the sine wave generator (11) into a square wave vibration.
- The therapeutic treatment device according to one of Claims 1 through 6, characterized in that a sine wave generator (11) and a pulse shaper (13) are provided, the pulse shaper (13) converting the sinusoidal oscillations generated by the sine wave generator (11) into a triangular vibration.
- The therapeutic treatment device according to one of Claims 1 through 7, characterized in that a sine wave generator (11) and a pulse shaper (13) are provided, the pulse shaper (13) converting the sinusoidal oscillations generated by the sine wave generator (11) into pulsed vibrations.
- The therapeutic treatment device according to one of Claims 1 through 8 having a storage medium for audio signals, characterized in that the audio signals essentially have frequencies which lie within predefined, discrete frequency bands below 100 Hz.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AT0136003A AT413077B (en) | 2003-08-29 | 2003-08-29 | THERAPEUTIC TREATMENT DEVICE |
PCT/AT2004/000294 WO2005020869A1 (en) | 2003-08-29 | 2004-08-27 | Therapeutic treatment appliance |
Publications (2)
Publication Number | Publication Date |
---|---|
EP1658032A1 EP1658032A1 (en) | 2006-05-24 |
EP1658032B1 true EP1658032B1 (en) | 2015-03-25 |
Family
ID=34229707
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP04761018.3A Expired - Lifetime EP1658032B1 (en) | 2003-08-29 | 2004-08-27 | Therapeutic treatment appliance |
Country Status (4)
Country | Link |
---|---|
US (1) | US20080214973A1 (en) |
EP (1) | EP1658032B1 (en) |
AT (1) | AT413077B (en) |
WO (1) | WO2005020869A1 (en) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK2106253T3 (en) * | 2007-01-10 | 2016-08-29 | Tipa Tinnitus Corp Pty Ltd | tinnitus Treatment |
DE102007003361A1 (en) | 2007-01-17 | 2008-07-31 | Patex Group Ltd. | Vibration therapy device |
US20090036805A1 (en) * | 2007-08-03 | 2009-02-05 | The Purrfect Device Inc. | Method and Apparatus for Providing an Animal Vocalization Driven Massage Device |
DE102008026629A1 (en) * | 2008-06-04 | 2009-12-10 | Ernst Radetzky | Treatment device, in particular for disc diseases |
US20110004048A1 (en) * | 2009-07-03 | 2011-01-06 | Henry Brunelle | Therapy devices and domestic/commercial therapy system |
RU2553080C2 (en) | 2009-12-02 | 2015-06-10 | Нестек С.А. | Machine for preparing beverages with function of emulation of environment |
US20130023804A1 (en) * | 2010-04-08 | 2013-01-24 | Koninklijke Philips Electronics N.V. | Sound massage system |
ITGO20120002A1 (en) * | 2012-03-22 | 2013-09-23 | Diego Kriscak | VIBROACUSTIC TABLE FOR REDUCING CELLULITE |
US10172761B2 (en) * | 2013-12-11 | 2019-01-08 | Ergomotion, Inc. | Vibratory system for massage and audio generation in an articulating bed |
US20160089298A1 (en) | 2014-09-29 | 2016-03-31 | Otolith Sound Inc | Device for Mitigating Motion Sickness and Other Responses to Inconsistent Sensory Information |
US11284205B2 (en) | 2016-11-14 | 2022-03-22 | Otolith Sound Inc. | Systems, devices, and methods for treating vestibular conditions |
US20180133102A1 (en) * | 2016-11-14 | 2018-05-17 | Otolith Sound, Inc. | Devices And Methods For Reducing The Symptoms Of Maladies Of The Vestibular System |
US10398897B2 (en) | 2016-11-14 | 2019-09-03 | Otolith Sound Inc. | Systems, devices, and methods for treating vestibular conditions |
CN110899076A (en) * | 2019-10-11 | 2020-03-24 | 泉州极简机器人科技有限公司 | Method and device for vibrating bed plate |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1063871A (en) * | 1962-07-05 | 1967-03-30 | George Walter De La Warr | Improvements relating to multi-frequency signal generating apparatus |
US3253077A (en) * | 1963-12-12 | 1966-05-24 | Park Baker Electronic Dev Corp | Electrical musical instrument keying circuitry |
US4112923A (en) * | 1976-08-24 | 1978-09-12 | Tomecek Jerry J | Antonomic transcutaneous affect device |
DE3541350A1 (en) * | 1985-11-22 | 1987-06-04 | Pius Voegel | THERAPY DEVICE FOR THE HUMAN BODY |
US5101810A (en) * | 1986-03-19 | 1992-04-07 | Vibroacoustics A/S | Apparatus and method for therapeutic application of vibro-acoustical energy to human body |
JPS6449559A (en) * | 1987-08-20 | 1989-02-27 | Toshio Takagi | Massager operated by acoustic signal |
DE3825454A1 (en) * | 1988-07-27 | 1990-02-01 | Gfpe Verlag & Seminar | LYING |
FI81959C (en) * | 1988-10-24 | 1991-01-10 | Salomo Murtonen | ANORDING FOR INFOERING AV VIBRATION I EN MAENNISKOKROPP. |
US5035235A (en) * | 1990-06-25 | 1991-07-30 | Chesky Kris S | Music vibration table and system |
NL9300938A (en) * | 1993-06-01 | 1995-01-02 | Lena De Visser | Device for delivering sound waves and / or a magnetic field to a patient. |
CA2131950A1 (en) * | 1993-09-16 | 1995-03-17 | Kazumi Masaki | Fm theta-inducing audible sound, and method, device and recorded medium to generate the same |
US5695455A (en) * | 1995-09-29 | 1997-12-09 | Sound Related Technologies, Inc. | Hydro-acoustic massage system and method |
IT1280961B1 (en) * | 1995-10-10 | 1998-02-11 | Istituto Deanna M Lanfranco Pe | DEVICE AND METHOD FOR THE MODULATION OF BIOLOGICAL FUNCTIONS. |
US6011852A (en) * | 1995-10-19 | 2000-01-04 | Howard; Albert R. | Audio power amplifier device for micro-computers |
FI106530B (en) * | 1996-10-08 | 2001-02-28 | Kaarlo Ilmari Railo | VIBRATOR |
US6544165B1 (en) * | 1999-07-23 | 2003-04-08 | Mcnew Barry | Method and apparatus for applying frequency vibrations therapeutically |
DE10040611A1 (en) * | 1999-08-18 | 2001-04-19 | Helmut Janowski | Vibro-massage bed, includes driven membrane excited by pipelines from chamber for massage of specific body regions |
US20030083599A1 (en) * | 2001-11-01 | 2003-05-01 | Zeev Kitov | Acoustic band vibration massage for muscle relaxation: method and device |
-
2003
- 2003-08-29 AT AT0136003A patent/AT413077B/en not_active IP Right Cessation
-
2004
- 2004-08-27 US US10/569,857 patent/US20080214973A1/en not_active Abandoned
- 2004-08-27 EP EP04761018.3A patent/EP1658032B1/en not_active Expired - Lifetime
- 2004-08-27 WO PCT/AT2004/000294 patent/WO2005020869A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2005020869A1 (en) | 2005-03-10 |
EP1658032A1 (en) | 2006-05-24 |
AT413077B (en) | 2005-11-15 |
ATA13602003A (en) | 2005-04-15 |
US20080214973A1 (en) | 2008-09-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1658032B1 (en) | Therapeutic treatment appliance | |
DE69729074T2 (en) | DEVICE FOR ULTRASONIC TREATMENT ADAPTED TO THE UPPER BODY | |
US8801591B1 (en) | Physical therapy whole sound frequencies device and method of using the same | |
DE102006026288A1 (en) | Bone conduction hearing aid is held by U arranged magnet pair with open end facing magnets implanted in skull | |
US9457166B1 (en) | Physical therapy whole sound frequencies device and method of recording content used therein | |
DE202011051018U1 (en) | Ultraschallfußmassagegerät | |
DE69425967T2 (en) | DEVICE FOR TREATING A PATIENT USING SOUND WAVES AND / OR A MAGNETIC FIELD | |
WO1989012433A1 (en) | Magnetic massage-therapy device | |
DE202005009361U1 (en) | Bone conduction hearing aid is held by U arranged magnet pair with open end facing magnets implanted in skull | |
DE60031675T2 (en) | BATHTUB, EQUIPPED WITH A WATER VIBRATOR | |
CH683822A5 (en) | Therapeutic treatment material to stimulate skin and tissue areas - has a pliable base with projections to give a non-invasive acupuncture pressure action | |
DE20321629U1 (en) | Muscle stimulation in a plaster-immobilized limb | |
DE202019103777U1 (en) | Physiotherapy glove with vibrations | |
AT522225B1 (en) | DEVICE FOR APPLICATION OF VIBRATION SIGNALS | |
CN107951700A (en) | A kind of low frequency electroacupuncture diagnosis and therapy apparatus | |
DE102017202847A1 (en) | Therapeutic treatment device | |
DE3207892A1 (en) | Footbath tub with ultrasonic treatment device | |
DE818679C (en) | Vibration device for therapeutic purposes | |
DE202020103850U1 (en) | Garment for massage and stimulation of the lymph flow | |
DE10310084A1 (en) | Treatment device for treating patient jaw diseases has a spreading assembly with which the inclination relative to the head of free ends of a support frame can be adjusted relative to the patient head without changing frame length | |
AT12578U1 (en) | FITNESS DEVICE | |
DE3812838A1 (en) | Small unit for the shock wave treatment of disorders | |
DE4340301A1 (en) | Device for increasing perfusion in organs for prophylax and sickness treatment | |
DE20208228U1 (en) | Combined frequency modulation, transfer and transformation system for the generation of phase-appropriate (harmonic) acousto-electro-magnetic fields in living organisms | |
DE102008045648A1 (en) | Oxygen singing bowl therapy (S-K-T) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20060227 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PL PT RO SE SI SK TR |
|
DAX | Request for extension of the european patent (deleted) | ||
GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
INTG | Intention to grant announced |
Effective date: 20140711 |
|
GRAS | Grant fee paid |
Free format text: ORIGINAL CODE: EPIDOSNIGR3 |
|
RAP1 | Party data changed (applicant data changed or rights of an application transferred) |
Owner name: VON OTHEGRAVEN, ACHIM Owner name: GRACENT AG, |
|
RIN1 | Information on inventor provided before grant (corrected) |
Inventor name: VON OTHEGRAVEN, ACHIM Inventor name: GRACENT AG, |
|
GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
AK | Designated contracting states |
Kind code of ref document: B1 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PL PT RO SE SI SK TR |
|
REG | Reference to a national code |
Ref country code: GB Ref legal event code: FG4D Free format text: NOT ENGLISH |
|
RIN1 | Information on inventor provided before grant (corrected) |
Inventor name: VON OTHEGRAVEN,ACHIM |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: EP |
|
RIN2 | Information on inventor provided after grant (corrected) |
Inventor name: VON OTHEGRAVEN, ACHIM |
|
REG | Reference to a national code |
Ref country code: IE Ref legal event code: FG4D Free format text: LANGUAGE OF EP DOCUMENT: GERMAN |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R096 Ref document number: 502004014860 Country of ref document: DE Effective date: 20150507 |
|
REG | Reference to a national code |
Ref country code: AT Ref legal event code: REF Ref document number: 717419 Country of ref document: AT Kind code of ref document: T Effective date: 20150515 |
|
REG | Reference to a national code |
Ref country code: NL Ref legal event code: T3 |
|
REG | Reference to a national code |
Ref country code: SE Ref legal event code: TRGR |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: FI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20150325 |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: PLFP Year of fee payment: 12 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: GR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20150626 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: EE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20150325 Ref country code: ES Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20150325 Ref country code: CZ Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20150325 Ref country code: RO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20150325 Ref country code: PT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20150727 Ref country code: SK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20150325 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: PL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20150325 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R097 Ref document number: 502004014860 Country of ref document: DE |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: DK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20150325 |
|
PLBE | No opposition filed within time limit |
Free format text: ORIGINAL CODE: 0009261 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT |
|
26N | No opposition filed |
Effective date: 20160105 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MC Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20150325 Ref country code: LU Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20150827 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20150325 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20150325 |
|
REG | Reference to a national code |
Ref country code: IE Ref legal event code: MM4A |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20150827 |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: PLFP Year of fee payment: 13 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: BG Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20150325 Ref country code: HU Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT; INVALID AB INITIO Effective date: 20040827 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: CY Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20150325 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: BE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20150831 |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: PLFP Year of fee payment: 14 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: TR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20150325 |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: PLFP Year of fee payment: 15 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: NL Payment date: 20180822 Year of fee payment: 15 Ref country code: FR Payment date: 20180824 Year of fee payment: 15 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: GB Payment date: 20180828 Year of fee payment: 15 Ref country code: SE Payment date: 20180827 Year of fee payment: 15 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: AT Payment date: 20190219 Year of fee payment: 15 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: DE Payment date: 20190822 Year of fee payment: 16 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: CH Payment date: 20190826 Year of fee payment: 16 |
|
REG | Reference to a national code |
Ref country code: NL Ref legal event code: MM Effective date: 20190901 |
|
REG | Reference to a national code |
Ref country code: AT Ref legal event code: MM01 Ref document number: 717419 Country of ref document: AT Kind code of ref document: T Effective date: 20190827 |
|
REG | Reference to a national code |
Ref country code: SE Ref legal event code: EUG |
|
GBPC | Gb: european patent ceased through non-payment of renewal fee |
Effective date: 20190827 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: AT Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20190827 Ref country code: SE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20190828 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: FR Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20190831 Ref country code: NL Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20190901 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: GB Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20190827 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R119 Ref document number: 502004014860 Country of ref document: DE |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: PL |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: CH Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20200831 Ref country code: LI Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20200831 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: DE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20210302 |